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Abstract
  . .Previous work Hashimoto et al., 1994 Biosci. Biotech. Biochem. 58, 1345 revealed that a sweet pepper extract
 .enhanced the tight-junctional TJ permeability of a human intestinal Caco-2 cell monolayer. In the present study, the
substance which modulated the TJ permeability was chromatographically purified from the extract. The active substances
were identified as capsianosides A–F, diterpene glycosides. Treatment of the cells with capsianoside F, the most active
compound, decreased the cellular G-actin content by 40% and increased the F-actin content by 16%. The effect of
capsianoside F was significantly suppressed by disturbing the cytoskeletal structure with cytochalasin D at a low dose 50
.ngrml . These results suggest that capsianosides affected the cytoskeletal function by modulating the reorganization of actin
filaments, by which the TJ structure and permeability were changed. The possible involvement of a PKC inhibition in the
mechanism of an increase in TJ permeability is also suggested.
Keywords: Caco-2 cell; Cultured epithelial monolayer; Tight junction; Capsianoside; Actin ring; Protein kinase C
Abbreviations: AR, actin ring; CD, cytochalasin D; DMEM,
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HBSS, Hanks’ balanced salt solution; LDH, lactic acid dehydro-
genase; LY, Lucifer yellow; PB, phosphate buffer; PBS, phos-
phate-buffered saline; PKC, protein kinase C; SDS, sodium dode-
cyl sulfate; TEER, transepithelial electrical resistance; TFA, tri-
fluoroacetic acid; TJ, tight junction; TPA, 12-O-tetradecanoyl-
phorbol-13-acetate; ZOT, zonula occludens toxin
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1. Introduction
The intestinal epithelial cell layer functions as a
barrier which separates the luminal and vascular fluid
compartments. This barrier function is substantially
 .dependent on the intercellular tight junction TJ that
restricts the flow through the paracellular pathway.
On the other hand, it is becoming evident that TJ
does not act as an impermeable gasket but is physio-
logically regulated in its permeability by intracellular
w x w xmessengers 1 or such surfactants as bile salts 2 .
The paracellular pathway is, therefore, thought to
provide a highly dynamic transport route for certain
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w xions and macromolecules 3 , contributing to the in-
testinal transport of various nutrients. Food compo-
nents that are orally ingested and present in the
intestinal lumen are also likely to participate in regu-
w xlating TJ permeability. Pappenheimer 4 first demon-
strated that the treatment of rat and hamster intestinal
mucosa by glucose or alanine increased the paracellu-
lar permeability, resulting in rapid absorption of the
nutrients. Alteration in macromolecular permeability
via the paracellular route by L-tryptophan has also
w xbeen reported by Madara and Carlson 5 .
In addition to these nutrients, there may be other
food-derived substances that modulate TJ. In the
w xprevious paper 6 , using a human intestinal Caco-2
cell monolayer as a model of the intestinal epithe-
lium, we demonstrated that milk whey proteins stabi-
lized TJ, the active substances being identified as
w xbovine serum albumin and b-lactoglobulin 7 . We
also found that a sweet pepper Capsicum annuum L.
.  .var. grossum extract contained some substance s
which reduced the transepithelial electrical resistance
 .TEER and increased the TJ permeability of the
Caco-2 monolayer. Caco-2 is a human colon carci-
noma cell line which spontaneously exhibits various
enterocytic characteristics; e.g., brush-border en-
w x w xzymes 8 , nutrient transporters 9–11 , and intercellu-
w xlar TJ 8 . The spontaneous formation of TJ in Caco-2
makes this cell a good in vitro model for investigat-
ing the regulation of intestinal TJ permeability.
The present study was undertaken to reveal the
TJ-modulatory substances in the sweet pepper ex-
tract. The active substances were isolated, their
molecular structures were determined, and the mech-
anism for TJ modulation by these substances was
investigated.
2. Materials and methods
2.1. Materials
The Caco-2 cell line was obtained from American
 .Type Culture Collection Rockville, MD, USA . Dul-
 .becco’s modified Eagle’s medium DMEM was ob-
 .tained from Nissui Tokyo, Japan , and fetal calf
 .  .serum FCS was from Bioserum Victoria, Australia .
Millicell-HA with 0.45-mm porosity cellulose mem-
branes of 12 mm in diameter and a Millicell-ERS
instrument with AgrAgCl electrodes were purchased
 .from Nihon Millipore Tokyo, Japan . A type-I colla-
gen solution was obtained from Nitta Gelatin Osaka,
.  .Japan , and a Hanks’ balanced salt solution HBSS
was from Life Technologies Grand Island, NY,
.  .USA . Lucifer yellow CH lithium salt LY , dextran-
 .Texas red of M 3000 DT-3K , propidium iodider
and rhodamine-labeled phalloidin were all from
 . Molecular Probes Eugene, OR, USA . DNase I type
.  .II from bovine pancreas , DNA calf thymus, type I
and pronase E were from Sigma Chemicals St.
.Louis, MO, USA . G-Actin was from Funakoshi
 .Tokyo, Japan , the Bio-Rad Protein Assay and Pro-
tein DC Assay reagents were from Bio-Rad Rich-
.  .mond, CA, USA . Lactic acid dehydrogenase LDH
 .Test Wako was from Wako Chemicals Osaka, Japan .
Non-radioisotopic Protein Kinase Assay System
 .NRPK assay system was from Upstate Biotechnol-
 .ogy Lake Placid, NY, USA , all other chemicals
being of reagent grade.
2.2. Cells and method of culture
Caco-2 cells were maintained in DMEM supple-
mented with 10% FCS, 4 mM L-glutamine, penicillin
at 50 IUrml and streptomycin at 50 mgrml. They
were incubated at 378C in a humidified atmosphere
of 5% CO in air. The cells were passaged at a split2
ratio of 4 to 8 every 3 or 4 days. For TEER measure-
ments and transport studies, cells were seeded on
Millicell-HA coated with type-I collagen at a density
of 2P105 cellsrcm2. For measuring the F-actin con-
tent, cells were seeded on a collagen-coated cover
glass in a 24-well plate at a density of 2P105
cellsrcm2.
2.3. TEER measurement
The TJ permeability of the Caco-2 cell monolayer
was evaluated by measuring the TEER value. TEER
is thought to be well correlated with the change in
w xparacellular permeability of the cell monolayer 12 .
After a 3-day culture of the cells on Millicell-HA, the
monolayer cells were rinsed with HBSS and then set
in a 24-well plate containing HBSS. HBSS was
added to the apical side, and the TEER value was
measured with a Millicell-ERS instrument. The TEER
value of the Caco-2 monolayer was measured before
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and after adding an assay sample, and the effect of
each assay sample is expressed as the relative TEER
value to the value at zero time.
2.4. Transport studies
The monolayer cells on Millicell-HA were set in a
24-well plate as just described. LY or DT-3K 100
.mgrml or 400 mgrml in HBSS, respectively was
added to the apical side, and the plate was then
incubated at 378C. After 1 h of incubation, the
medium was collected from the basal side, and the
concentrations of LY and DT-3K were determined by
measuring the fluorescence intensity of each with an
 .F-4000 spectrophotofluorometer Hitachi, Japan . The
excitation–emission wavelengths were 430–540 nm
for LY and 568–607 nm for DT-3K.
2.5. Isolation of the acti˝e compounds
 .Two ml of a sample solution 30 mgrml in a 50
mM formic acid–ammonium buffer at pH 8.0 was
applied to a column of DEAE-Toyopearl 650M 10
.=110 mm; Tosoh, Japan that had been equilibrated
with the same buffer. The adsorbed materials were
recovered by eluting with a 500 mM formic acid–
ammonium buffer at pH 6.0, using a flow rate of 0.8
mlrmin.
An aqueous sample solution was applied to a
 .Sep-Pak-C cartridge 10 g; Millipore, MA, USA18
that had been equilibrated with deionized and dis-
 .tilled water DDW . The adsorbed materials were
recovered by stepwise elution with 0–50% aceto-
nitrile.
A lyophilized Sep-Pak fraction was dissolved in
DDW and then applied to a Superose 12 column
 .8=300 mm; Pharmacia Biotech, Japan that had
been equilibrated with DDW. The flow rate was 15
 .mlrh, and the eluate 0.5-ml fractions was moni-
tored at 280 nm with a Bio mini UV monitor Atto,
.Japan . For measuring the hexose content, 0.1 ml of
each fraction was served for the phenol–sulfuric acid
w xmethod 13 . The residue of each fraction was
lyophilized and then used for the assay of TEER-de-
creasing activity.
The active fraction was further purified by HPLC.
A sample solution was injected into HPLC equipment
 .Gulliver system, Jasco, Japan that was equipped
with a YMC-pack ODS-AM column 4.6=250 mm;
.YMC, Japan that had been equilibrated with 0.1%
 .trifluoroacetic acid TFA . Elution was carried out
with 0.1% TFA–acetonitrile as the mobile phase at a
flow rate of 1.0 mlrmin, the eluate being monitored
at 210 nm. To prepare the samples for structural
analyses, the mobile phase was replaced with
DDW–acetonitrile, and for preparative-scale experi-
ments, a YMC-pack ODS-AM column 10=250
.mm was also used.
2.6. Structural analyses
NMR experiments were conducted with a JEOL
a-500 spectrometer, while FAB-MS spectra were
recorded with a JEOL DX-303HF mass spectrometer.
2.7. Surface acti˝ity
Surface activity was measured with a Wilhelmy
plate type surface tensiometer Kyowa CBVP surface
.tensiometer A3, Kyowa Kagaku, Tokyo, Japan using
 .a glass plate 24=24 mm at 198C.
2.8. Membrane permeability
The intercalating dye, propidium iodide, was used
w xto evaluate the cell membrane permeability 14 . A
Caco-2 cell monolayer grown on a collagen-coated
cover glass for 3 days was treated for 15 min with or
without each sample to be tested. After the incuba-
tion, the cells were rinsed and then stained with
propidium iodide at 50 mgrml. The stained material
was observed by fluorescence microscopy.
2.9. Ca2q-chelating acti˝ity of the capsianosides
The chelating activity of capsianoside F was evalu-
ated as relative to the activity of EDTA. Several
concentrations of capsianoside F or EDTA were added
to a 1 nM quin-2 solution, in which quin-2 had been
chelating Ca2q in DDW, and the fluorescence inten-
sity was measured with a F-4000 spectrophotofluo-
rometer. The excitation–emission wavelengths were
334–490 nm. The relative chelating activity was
determined by comparing the dose that was needed to
reduce the fluorescence intensity by 0.5.
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2.10. Determination of cellular actin
F-actin. The relative content of F-actin was de-
termined by a fluorescent phalloidin-binding assay
w x15 . Caco-2 cell monolayers that had been incubated
on a cover glass for 3 days were rinsed with HBSS
and then incubated for 15 min more with or without a
sample being tested. After the incubation, the cell
monolayers were fixed with acetonermethanol 1:1,
.  .v:v , and then the actin ring AR was stained for 20
min with rhodamine-labeled phalloidin diluted 10-
 .times with phosphate-buffered saline PBS . Stained
cells were extracted with 2 ml of methanol, and the
fluorescence intensity of the extract was measured
with a F-4000 spectrophotofluorometer. The excita-
tion–emission wavelengths were 545–578 nm.
G-actin. The G-actin content was determined by
w xa DNase I inhibition test 16 . Caco-2 cell monolayers
that had been incubated on a 24-well plate for 3 days
were rinsed with HBSS and then incubated for 30
min more with or without a sample being tested.
After the incubation, the cells were lysed in a 50 mM
 .Tris-HCl buffer at pH 7.5 500 ml per well , contain-
ing 1% Triton X-100, 2 mM MgCl and 1 mM2
 . X Xethylenedioxybis ethylamine -N,N,N ,N -tetraacetic
 .acid EGTA . Twenty ml of a DNase I solution at
100 mgrml in 50 mM Tris-HCl at pH 7.5, containing
0.1 mM CaCl and 10 mM phenylmethylsulfonyl-2
fluoride was added to 100 ml of the cell lysate. Three
ml of DNA at 80 mgrml in 100 mM Tris-HCl pH
.7.5 , containing 4 mM MgSO and 1.8 mM CaCl ,4 2
was also added to the mixture. The cellular G-actin
content was determined by measuring the rate of
absorbance increase at 260 nm, using purified rabbit
muscle G-actin as a standard. The protein content
was determined with a Bio-Rad protein assay reagent
w x17 , the G-actin content being expressed as mg of
G-actin per mg of protein.
2.11. In ˝itro PKC assay
Cell treatment and subcellular fractionation.
Confluent Caco-2 monolayers on a 100-mm culture
dish were rinsed twice with HBSS, and then incu-
 .bated with or without capsianoside F 50 mgrml at
378C for 30 min. After removing the medium, the
cells were quickly rinsed with ice-cold HBSS and
 .then scraped in 25 mM Tris buffer pH 7.5 , contain-
ing 2 mM EDTA, 0.5 mM EGTA, 1 mM dithio-
threitol, 20 mgrml leupeptin, 20 mgrml aprotinin, 1
mM 4-amidinophenylmethanesulfonyl fluoride and
 .0.2 mgrml Triton X-100 2 mlrdish . The cells were
homogenized with Polytron PT-MR3000, Kine-
.matika AG, Littau, Switzerland for 30 s, and the
lysates were centrifuged at 100 000=g for 30 min
 .Beckman TLA-100.3, fixed angle rotor , the super-
natants being used as cytosolic fractions. The protein
concentration of the fractions was determined with a
w xProtein DC Assay reagent 18 .
Measurement of PKC. The PKC content was
measured by a NRPK assay system, which was based
 .on an enzyme-linked immunosorbent assay ELISA
w x19 . Briefly, 15 mg of the cytosolic protein was
incubated with a synthetic peptide corresponding to
the residues 3–13 of porcine glial fibrillary acidic
protein which had been coated on microwell plates.
The phosphorylated peptides were detected by incu-
bating with the monoclonal antibody, YC-10, fol-
lowed by incubating with anti-mouse IgG conjugated
to peroxidase. Peroxidase substrate was added to the
microwells, and the color intensity was measured
photometrically at 415 nm. Results were shown as
the ELISA values.
2.12. Statistical analyses
All results are expressed as mean"S.D. Student’s
t-test was used to compare means and ranges.
3. Results and discussion
3.1. Isolation and partial characterization of the
acti˝e substance from the sweet pepper extract
The crude sweet pepper extract, which had been
w xprepared as described previously 20 , was dialysed
against DDW. The lyophilized material was dissolved
in a 50 mM formic acid-ammonium buffer and ap-
plied to a DEAE-Toyopearl ion-exchange column.
The passed-through fraction having TEER-decreasing
activity was then applied to a Sep-Pak-C cartridge,18
and the adsorbed materials were recovered by step-
wise elution with acetonitrile. The highest activity
was detected in the Sep-Pak fraction eluted with
 .between 30% and 50% acetonitrile data not shown .
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Fig. 1. Purification of the TEER-decreasing substances. The
Sep-Pak fraction with TEER-decreasing activity was further frac-
tionated in a Superose 12 column. The isolated fractions were
 .each assayed for TEER-decreasing activity v . The protein
content was monitored by measuring the absorbance at 280 nm
 .’ . The hexose content was measured by the phenol–sulfuric
 .acid method and is shown by the absorbance at 480 nm ‘ .
After a 30-min exposure of the Caco-2 cell mono-
layer to this fraction from the apical side at a concen-
tration of 300 mgrml, the TEER value was reduced
to 60% of the value at zero time.
The active fraction was further fractionated by
Superose 12 chromatography, and the TEER-decreas-
ing activity of the fractions was measured. As shown
in Fig. 1, the fractions from No. 25 to No. 29 named
.SP-Fr decreased the TEER value to less than 70% of
the value at zero time. An analysis of all the fractions
for hexoses by the phenol–sulfuric acid method
showed SP-Fr to be rich in hexose, whereas the
protein content of SP-Fr seemed to be small. No
significant change was apparent in the TEER-de-
creasing activity of SP-Fr by heating at 1008C or by
 .Pronase treatment data not shown . These experi-
mental results suggest that the active substance in
SP-Fr was not a proteinaceous material, but rather a
thermally stable complex carbohydrate or a related
substance. The yield of SP-Fr was 27.5"2.8 mg
 .from 100 g wet weight of sweet pepper.
Various concentrations of SP-Fr were added to the
apical side of the Caco-2 cell monolayer in HBSS
and incubated at 378C for 30 min. The TEER-de-
creasing activity of SP-Fr increased with increasing
concentration and reached a plateau at about 200
mgrml, at which the TEER value was decreased to
60% of the value at zero time. The half-maximal
TEER-decreasing dose was 110 mgrml.
Cytotoxic materials may damage the cell mono-
w xlayer, resulting in a TEER decrease 20 . An optical
microscopic observation, however, indicated that no
detachment of cells from the monolayer was induced
 .by the SP-Fr treatment data not shown . No signifi-
cant difference in the amount of LDH released from
the cells was observed between the SP-Fr-treated
 . 300 mgrml; 2.9"0.7%, ns3 and control 2.1"
.0.2%, ns3 cells. The decrease in TEER caused by
SP-Fr was not an irreversible change, and when the
medium containing SP-Fr was removed from the
apical side of the cell layer and the cells were
incubated in a culture medium containing 10% FCS,
the TEER value of the monolayer had completely
recovered after 5 h the relative TEER value was
0.55"0.05 for the cells after a 30-min treatment
 .with SP-Fr 200 mgrml , while the value was in-
creased to 1.08"0.04 in 5 h after removing the
.SP-Fr, ns4 . These experimental results suggest
that the decrease in TEER value by the SP-Fr treat-
ment was not due to any damage to the cell mono-
layer, but rather due to the reversible opening of a
paracellular route.
3.2. Effect of SP-Fr on the permeability of the cell
monolayer
The effect of SP-Fr on the permeability of the cell
monolayer was examined by using such leakage
markers as LY and DT-3K. After 1 h of incubation
with LY or DT-3K in the presence of SP-Fr 200
.mgrml , the medium on the basal side was collected,
and the leakage-marker concentration was determined
by measuring the fluorescence intensity. The SP-Fr
treatment increased the permeability for LY Mr
.  .457.24 and DT-3K average M of about 3000 byr
 .120% and 30%, respectively Fig. 2 , suggesting that
the opening of the paracellular route was not due to
TJ destruction, but due to a subtle modulation of the
TJ structure.
3.3. Purification and identification of the acti˝e sub-
stances in SP-Fr
An HPLC analysis of SP-Fr, using an ODS col-
umn, indicated at least five major components SP-
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Fig. 2. Effect of SP-Fr on the permeability of the Caco-2
monolayer. The permeability of the Caco-2 cell monolayer was
examined with LY and DT-3K as leakage markers. Data bars
represent the means"S.D. for four samples. Shaded bars, con-
 . )trol; open bars, treated with SP-Fr 200 mgrml . Significantly
 .different P -0.001 from the control sample.
.1–5; Fig. 3 . SP-1–5 corresponding to the five major
peaks by HPLC were purified by rechromatography,
and the structure of SP-1–5 was then analyzed by
1H- and 13C-NMR and FAB-MS. SP-1–5 had a
similar structure and were identified as capsianosides,
dimeric esters of monomeric diterpene glycosides.
Fig. 3. Reverse-phase HPLC of SP-Fr in a YMC-Pack ODS-AM
column. 800 mg of SP-Fr was applied to the column. The elution
 .profile acetonitrile concentration is shown by the broken line.
 .Fig. 4. Structures of capsianosides A–F. a Capsianosides A, C
 .and E. b Capsianosides B, D and F.
SP-1, 3, 4 and 5 corresponded to capsianosides C, E,
B and F, respectively, while SP-2 was a mixture of
 .capsianosides C and D Fig. 4 . SP solutions in
HBSS were centrifuged at 16 000=g and the SP-
content in the supernatants was determined by HPLC
analysis. SP-1–5 were all soluble in HBSS within the
concentrations used in this experiment up to 200
.mgrml .
The TEER-decreasing activity of SP-1–5 varied
according to each, suggesting a relationship between
the structure and activity of the capsianosides Fig. 3
.and Fig. 5 . For example, capsianosides C and E,
whose TEER-decreasing activity was lower than that
of the other capsianosides, were less hydrophobic
retention times by reversed-phase HPLC were
.shorter , whereas capsianoside B and F were more
hydrophobic than the other capsianosides. This differ-
ence in hydrophobicity seem to have been dependent
on the different mode of ester bonding between the
inner rhamnosyl moiety and the terpene glycoside
Fig. 4a for capsianosides C and E, and Fig. 4b for B
. and F . The co-incubation of capsianoside C 100
.mgrml with Pluronic F-127, a reagent which in-
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creases the permeability of the cell membrane for
w xhydrophilic substances 21 , rendered decrease in the
 .TEER value Fig. 6 , indicating penetration through
the cell membrane to be an important step for the
TEER-decreasing activity of capsianosides.
Capsianosides A–F had already been isolated from
various Capsicum annuum species and their struc-
tures determined by spectroscopic and chemical
w xmeans 22 . However, the physiological functions of
capsianosides are hardly known, except for the in-
hibitory activity toward the angiotensin-converting
w xenzyme of capsianosides C and D 21 . A new func-
tion of capsianosides, i.e., the regulation of paracellu-
lar absorption in the intestine, has therefore been
revealed by the present study.
3.4. Chemical and physicochemical properties of
capsianosides
Uvomorulin, a Ca2q-dependent adhesion molecule,
mediates cell–cell adhesion that is a prerequisite for
the assembly of the intracellular junctional complex
w x 2qinvolving TJ 23 . Ca removal would affect these
Ca2q-dependent adhesion molecules, inducing the
disassembly of cytoskeletal and junctional compo-
w x 2qnents 14 . The Ca -chelating activity of cap-
sianoside F was therefore investigated using quin-2
Fig. 5. Dose dependency of SP-1–5 for TEER-decreasing activ-
ity. The Caco-2 cell monolayer was treated with the indicated
amounts of SP-1–5 for 30 min at 378C. The TEER values are
presented as relative to the values at zero time. The values shown
 .  .are the mean"S.D. bars for four samples. ‘ SP-1; ^ SP-2;
 .  .  .I SP-3; v SP-4; ’ SP-5.
Fig. 6. Effect of Pluronic F-127 on the TEER-decreasing activity
of capsianoside F. Cells were pretreated with Pluronic F-127 200
. mgrml for 15 min, and then treated with capsianoside C 100
.mgrml for up to 45 min. The TEER values are presented as
relative to the values at zero time. The values shown are the
 .means"S.D. ns3 bars, unless the error bar is smaller than the
 .  .  .symbol. ‘ control; v capsianoside C; ^ Pluronic F-127;
 . )’ Pluronic F-127 and capsianoside C. Significantly different
 . ))P -0.025 from the control sample. Significantly different
 . )))P -0.005 from the Pluronic F-127-treated cells. Signifi-
 .cantly different P -0.001 from the Pluronic F-127-treated
cells.
as a Ca2q-specific indicator. Capsianoside F was
observed to have a Ca2q-chelating activity, about
 .one-tenth that of EDTA data not shown . Previous
studies using certain epithelial cell lines demonstrated
that Ca2q removal by chelating agents did not initiate
the disintegration of TJ when the agents were added
w xfrom the apical side 24–27 . Capsianosides, how-
ever, decreased the TEER value from any side of the
monolayer the relative TEER value was 0.67"0.07
from the apical side, and 0.71"0.04 from the basal
. 2q  .side, ns3 . Further addition of Ca up to 4 mM
to the incubation medium did not affect the activity
of SP-Fr the relative TEER values were 0.63"0.06
in the presence of 4 mM Ca2q and 0.63"0.02 for
.the control, ns3 . Consequently, it is unlikely that
the increased monolayer permeability by capsiano-
sides was due to its Ca2q-chelating activity.
Capsianosides A–F were shown to be surface ac-
 . w xtive Fig. 7 . Anderberg and Artursson 28 have
reported that the treatment of Caco-2 monolayers
with such surface active substances as SDS increased
2q w 2qx .the intracellular Ca level Ca , resulting ini
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w 2qxincreased TJ permeability. This increase in Ca i
was probably due to the stimulation of Ca2q release
from the intracellular store andror the influx of
extracellular Ca2q caused by the increased cell mem-
brane permeability. Treatment with capsianoside F
 .50 mgrml , however, neither increased the cell
w 2qxmembrane permeability nor induced increased Ca i
 .data not shown . Although the TEER-decreasing
 .activity of capsianosides A–F Fig. 5 seems to be
 .correlated with the surface activity Fig. 7 , the
mechanism for the increase in TJ permeability by
capsianosides was thought to be different from that
by SDS. Probably, the surface active properties of
capsianosides relate to their penetrability to cell
membranes, thus affecting the TEER-decreasing ac-
tivity.
3.5. Effect of capsianosides on the cytoskeletal struc-
ture of Caco-2
A linkage between TJ components and the actin
 . w xring AR has been shown 29 . Recently, Stuart and
w xNigam 30 reported that the TJ-associated protein
w x w xcomplex, involving ZO-1 31 , ZO-2 32 and oc-
w xcludin 33 , associated with cytoskeletal elements.
The functional association of AR and TJ was sug-
 .gested by the experiments using cytochalasin D CD
which was known to perturb the cytoskeletal struc-
w xture 34,35 . The TEER value of the Caco-2 cell
 .monolayer after a 30-min exposure to CD 10 mgrml
Fig. 7. Surface activity of capsianosides. SP-1–5 were dissolved
in DDW at various concentrations. The values shown are the
means of three replications. The S.D. bars were smaller than the
 .  .  .  .  .symbol. ‘ SP-1; ^ SP-2; I SP-3; v SP-4; ’ SP-5.
Fig. 8. Effect of capsianoside F on the cellular G- and F-actin
contents. Data bars represent the means"S.D. for four samples
 .  .G-actin and for three samples F-actin . Shaded bars, control;
 . )open bars, treated with SP-Fr 50 mgrml . Significantly differ-
 . ))ent P -0.05 from the control sample. Significantly differ-
 .ent P -0.005 from the control sample.
was also reduced to 60% of the value at zero time.
Perturbing the cytoskeletal structure, therefore,
seemed to be the major mechanism for the TEER-de-
creasing activity of capsianosides. In order to reveal
the effect of capsianosides on the cytoskeletal struc-
ture, the cellular G- and F-actin contents were deter-
 .mined Fig. 8 . The intracellular G-actin content was
decreased to 60% by treating with capsianoside F at
50 mgrml for 30 min. In contrast, the relative F-actin
content was increased by 16% by the capsianoside F
treatment at 50 mgrml for 15 min. Pretreatment of
the cells for 30 min with a low concentration 50
.ngrml of CD, which had been reported to perturb
the cytoskeletal structure but not to reduce the TEER
w xvalue at this concentration 36 , significantly reduced
the activity of capsianoside F the relative TEER
values were 0.42"0.06 for the cells without CD-pre-
treatment and 0.64"0.07 with pretreatment, P-
.0.01, ns3 . These findings strongly suggest that
capsianoside F stimulated the reorganization of the
actin filaments, by which the TJ permeability was
increased.
3.6. Effect of capsianosides on the acti˝ity of PKC
The protein kinase inhibitor has been shown to
block junctional dissociation caused by Ca2q-chelator
w x w x w x37,38 , CD 39 or zonula occludens toxin 40 treat-
ment. However, the pretreatment with a PKC in-
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Table 1
Effect of TPA on the TEER-decreasing activity of capsianoside F
 .TPA ngrml relative TEER
0 0.45"0.02
0.5 0.50"0.06
))1 0.52"0.03
))5 0.54"0.04
)10 0.57"0.07
Cells were pretreated with various concentrations of TPA for 15
min from both the apical and basal sides, and then treated with
 .capsianoside F 50 mgrml from the apical side for 15 min. The
TEER values are presented as relative to the values at zero time.
Values present the mean"S.D. for three samples.
)  .Significantly different P -0.05 from the cells without TPA-
))  .treatment; significantly different P -0.025 from the cells
without TPA-treatment.
 .hibitor, H-7 20 mM , had no effect on the TEER-de-
 .creasing activity of capsianoside F data not shown ,
suggesting that phosphorylation by PKC did not play
a part in the disassembly of TJ by capsianoside F. On
the other hand, pretreatment of Caco-2 cells with
 .12-O-tetradecanoyl-phorbol-13-acetate TPA , a PKC
activator which was reported to cause immediate
w xactivation of PKC of Caco-2 cells 41 , significantly
reduced the TEER-decreasing activity of cap-
 .sianoside F Table 1 . PKC-activation therefore seems
to have negative effects on the disassembly of TJ by
w xcapsianoside F. Balda et al. 48 reported that the
PKC activator stimulated the assembly of TJ. It has
been reported that PKC activation was accompanied
with the translocation of this enzyme from the cy-
w xtosol to the plasma membrane 42–47 . In our prelim-
inary experiment, the amount of PKC in the cytoplas-
 .mic fraction significantly increased P-0.05 after a
 . capsianoside F-treatment 50 mgrml for 30 min the
ELISA values, which reflect the amount of PKC,
were 0.037"0.009 for the control and 0.070"0.011
.for the capsianoside F-treated cells, ns3 . There-
fore, capsianosides seemed to reduce the cellular
PKC, that might interfere with the maintenance of
barrier functions and increase the TJ permeability.
The mechanism for the PKC inhibition by capsiano-
sides must be further investigated.
3.7. Concluding remarks
The results presented here lead to our postulated
mechanism for the TEER-decreasing activity of cap-
sianosides. Capsianosides pass through or are inserted
into the cell membrane, after which they stimulate
AR reorganization. Participation of PKC in the reor-
ganization of actin filaments was also suggested.
These effects would modulate the TJ structure, result-
ing in increased TJ permeability.
The present study has demonstrated that capsiano-
sides would be useful to enhance the permeability for
drugs or other biologically important hydrophilic sub-
stances across the intestinal mucosa. As capsiano-
sides maintain their activity in the presence of a high
concentration of Ca2q, they would, for example, be
able to enhance Ca2q permeability. Since the major-
ity of Ca2q in the intestinal tract is transported by the
w xparacellular pathway 49 , capsianosides may lead to
increased Ca2q intake from the lumen into the vascu-
lar fluids.
Although capsianosides increased TJ permeability,
this does not mean that the paracellular route would
be wide-open without any restrictions. The enhance-
ment of DT-3K permeability by capsianoside was
 .much smaller than that of LY permeability Fig. 2 ,
suggesting that the permeability for large molecules,
which could become allergens, would be restricted to
a higher degree than that for drugs and Ca2q.
Capsicum species have long been used as a food,
and for spices and external medicines. The physio-
logical functions of Capsicum substances in the hu-
man body are therefore of great interest. The present
study demonstrated that capsianosides, diterpene gly-
cosides, contained in Capsicum plants could modu-
late the intestinal absorptive functions. The in vivo
effect of capsianosides on the absorption of certain
nutrients including Ca2q will be the subject of a
further study.
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